Goal 18: Renal function tests—people with type 2 diabetes

This indicator reports on the proportion of Aboriginal and Torres Strait Islander people with type 2 diabetes who had a kidney (renal) function test in the previous 12 months and are regular clients attending Indigenous specific primary health care services. The goal for this indicator is 69% by 2023.

Why is it important?

Chronic conditions, including diabetes, are the leading causes of illness, disability and death among Aboriginal and Torres Strait Islander people. Effective management and monitoring of diabetes, including regular renal function tests, can delay the progression of disease, improve quality of life and increase life expectancy.

What data are available?

In the absence of national data on Aboriginal and Torres Strait Islander people with type 2 diabetes who have regular renal function tests, this indicator uses data from the Indigenous primary health care national Key Performance Indicators (nKPIs) data collection. These data pertain to Indigenous regular clients. A regular client is defined as a client who has attended the primary health care organisation at least 3 times in the last 2 years.

What do the data show?

Progress towards the goal is not on track.

  • The proportion of Indigenous regular clients with type 2 diabetes who had a kidney function test result recorded within the previous 12 months increased from 63% in December 2017 to 65% in December 2019.
  • From December 2017, the rates were consistently below the trajectory required to meet the goal in 2023.

Nationally, in December 2019, among Aboriginal and Torres Strait Islander regular clients aged 15 and over with type 2 diabetes:

  • 65% had a kidney function test result recorded within the previous 12 months, which was below the trajectory point (67%) required to meet the goal by 2023.
  • the proportion who had a kidney function test recorded in the past 12 months was highest in Queensland (47%) and lowest in Victoria/Tasmania (38%).

Figure 18.1: Aboriginal and Torres Strait Islander regular clients with type 2 diabetes who had a kidney function test result recorded in the previous 12 months

The figure shows the baseline data, from June 2013 to June 2014, the trajectory towards the goal, from December 2014 to June 2023. New data show the proportion of Indigenous regular clients with type 2 diabetes who had a kidney function test result recorded in the previous 12 months from December 2014 to December 2019. Most recent data from June 2019 show that 64.5% of Indigenous clients had a result recorded in the previous 12 months.

Visualisation not available for printing

Figure 18.2: Aboriginal and Torres Strait Islander regular clients with type 2 diabetes who had a kidney function test result recorded in the previous 12 months, by age group, December 2019

Visualisation not available for printing

Figure 18.3: Aboriginal and Torres Strait Islander regular clients with type 2 diabetes who had a kidney function test result recorded in the previous 12 months, June 2019 and December 2019

The figure shows the rate of blood pressure test results recorded among regular clients with type 2 diabetes by remoteness. In December 2019 the rate was highest in Remote areas (50.7%) but lowest in Very remote areas (39.7%).

Visualisation not available for printing

Figure 18.4: Organisations' results against the 2019 trajectory and 2023 goal for kidney function test results recorded, December 2019

The figure shows the proportion of services on the x-axis and the per cent of clients with a result recorded on the y axis. Two lines are drawn across the chart to show the December 2019 IP goal and the 2023 IP goal. The graph shows that 35.5% of services had 67.3% or more of clients with a result recorded (the Deember 2019 goal).

 

 

Visualisation not available for printing